ESPEROVAX
Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.
ESPEROVAX
Industry:
Biotechnology
Address:
Plymouth, Minnesota, United States
Country:
United States
Website Url:
http://www.esperovax.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Current Advisors List
Current Employees Featured
Founder
Investors List
Tech Startup Stabilization Fund
Tech Startup Stabilization Fund investment in Venture Round - Esperovax
Official Site Inspections
http://www.esperovax.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.42 K
- Host name: 192-185-144-146.unifiedlayer.com
- IP address: 192.185.144.146
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Esperovax"
Esperovax - Crunchbase Company Profile & Funding
Esperovax is a biotechnology company based in Plymouth, MI. Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.See details»
Esperovax Company Profile 2024: Valuation, Funding
Esperovax General Information Description. Developer a novel vaccine technology intended to deliver oral vaccines and therapeutics to patients. The company's platform leverages molecular-based technology to effectively target …See details»
Esperovax Company Profile: Overview and Full News Analysis
Esperovax's technology allows for large-scale production and distribution of shelf-stable vaccines at a fraction of the cost of traditional injection-based treatments. Esperovax's mission is to lead …See details»
ESPEROVAX, INC. Company Profile | Plymouth, MI | Competitors ...
Find company research, competitor information, contact details & financial data for ESPEROVAX, INC. of Plymouth, MI. Get the latest business insights from Dun & Bradstreet.See details»
Esperovax Appoints Dr. Robin Robinson as President and CEO
May 1, 2023 Esperovax Board Chairman Roger Newton commented: "The appointment of Dr. Robinson as CEO marks a notable milestone for Esperovax, an organization committed to …See details»
Esperovax Awarded Subcontract for Development of …
Dec 12, 2024 Esperovax, Inc., a private Michigan-based biotechnology company specializing in innovative circular RNA technologies announced today that DynPort Vaccine Company LLC …See details»
Esperovax LLC Overview - Salary.com
Esperovax LLC Information BETA. Headquarters Address: 46701 Commerce Center Dr, Plymouth, Michigan. Phone Number: +1 2486671845. Revenue: $1 Million - $5 Million ... The …See details»
Esperovax - UM - Innovation Partnerships
Esperovax is a startup developing novel mRNA oral vaccines. Launch: 2023. Subscribe to Our Newsletter . 1600 Huron Pkwy, Building 520, 2nd Floor Ann Arbor, MI 48109-2590 734-763 …See details»
Esperovax Awarded Subcontract for Development of …
Dec 12, 2024 About Esperovax: Esperovax, Inc. is a private U.S.-based biotechnology company focused on developing next-generation oral RNA vaccine and therapeutic platforms and …See details»
Esperovax, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Esperovax, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, and 2 literature, Disease Domain:Infectious Diseases, Technology Platform:Prophylactic vaccine, …See details»
ESPEROVAX SIGNS EXCLUSIVE LICENSING AGREEMENT WITH THE …
Nov 30, 2022 Esperovax was founded in 2019 to advance development of its Egress RDâ„¢ oral mRNA platform, a transformative technology for delivering mRNA vaccines to the abundant …See details»
Esperovax Awarded Subcontract for Development of ... - BioSpace
PLYMOUTH, Mich., Dec. 12, 2024 /PRNewswire/ -- Esperovax, Inc., a private Michigan-based biotechnology company specializing in innovative circular RNA technologies announced today …See details»
Medical Countermeasures | BARDA establishes four new …
Aug 26, 2020 Esperovax: Esperovax looks to become the global leader in oral tablet/capsule vaccinations for some of the world's deadliest treatable diseases by leveraging its new oral …See details»
Esperovax and Ginkgo Bioworks Announce Partnership to Develop …
Jan 5, 2023 Initial focus of partnership will aim to develop cancer therapeutics . PLYMOUTH, Mich. and BOSTON, Jan. 5, 2023 /PRNewswire/ -- Esperovax, an innovative developer of oral …See details»
Esperovax Awarded $1M for Development of an Oral COVID-19 …
Oct 3, 2023 About Esperovax: Esperovax was founded in 2019 to advance development of its Egress RDâ„¢ oral mRNA platform, a transformative technology for delivering mRNA vaccines …See details»
mRNA vaccine - ESPEROVAX - AdisInsight
03 Oct 2023 Esperovax plans preclinical studies for COVID-19 infections (Prevention) in USA ; 30 Nov 2022 Early research in COVID-19 infections (Prevention) in USA (PO) You need to be a …See details»
Esperovax - Drug Discovery World (DDW)
Jan 10, 2023 Esperovax and Ginkgo Bioworks have agreed a partnership to develop circular RNAs (circRNAs) for a variety of therapeutic applications. Initially, the companies will work to …See details»
Esperovax Awarded New Contract With BARDA - PR Newswire
Sep 23, 2020 Esperovax has developed a proprietary method for bioengineering probiotic yeast to deliver continuous and high concentrations of vaccine antigen in the gut. These antigens …See details»
Esperovax - Company Profile - Tracxn
Esperovax - Developer of an oral vaccine for infectious diseases. from 2 investors. Founded by David O'Hagan, Savita Nikam and 1 other in the year 2018. Esperovax has 145 competitors. …See details»
Esperovax and Ginkgo Bioworks Announce Partnership to Develop …
Jan 5, 2023 Esperovax was founded in 2018 to advance the development of its Egress RDâ„¢ oral vaccine platform, a transformative technology for delivering vaccines to the abundant …See details»